Clincosm LogoSign in Get a demo

Risk of Bacterial Exposure to the Anesthesiologist's Face During Intubation and Extubation

Sponsor
Yonsei University (Other)
Overall Status
Completed
CT.gov ID
NCT04673006
Collaborator
(none)
66
Enrollment
1
Location
5.6
Actual Duration (Months)
11.7
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

The practice of intubation and extubation is not without risks to the anesthesiologists. Especially, the face of health care worker is the body part most commonly contaminated by splashes and sprays of body fluids. The aim of this study is to determine the incidence of unrecognized exposure to the anesthesiologists' face during endotracheal intubation and extubation. We will perform face shield swab before and after the endotracheal intubation and extubation. All swabs will be cultured for 48 hours and the number of colony forming units before and after the procedures (intubation/extubation) will be compared.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    66 participants
    Observational Model:
    Case-Only
    Time Perspective:
    Prospective
    Official Title:
    Risk of Bacterial Exposure to the Anesthesiologist's Face During Intubation and Extubation
    Actual Study Start Date :
    Jan 8, 2021
    Actual Primary Completion Date :
    Jun 28, 2021
    Actual Study Completion Date :
    Jun 28, 2021

    Arms and Interventions

    Arm Intervention/Treatment
    anesthesiologists who will perform endotracheal intubation and extubation for general anesthesia

    All anesthesiologists in this study will use face shield for facial protection. Face shield swab will be done before and after the procedures (intubation and extubation)

    Outcome Measures

    Primary Outcome Measures

    1. Bacterial growth of face shield swab after the endotracheal extubation [Bacterial swab will be performed 5 minutes after the endotracheal extubation (after the confirmation of sufficient spontaneous breathing)]

      All swab will be cultured for 48 hours and will be reported as no growth or by number of colony forming unit(CFU)s. The number of CFU of post-extubation swab will be compared with that of pre-extubation swab.

    Secondary Outcome Measures

    1. Bacterial growth of face shield swab after the endotracheal intubation [Bacterial swab will be performed 5 minutes after the endotracheal extubation (after the confirmation of adequate mechanical ventilation)]

      All swab will be cultured for 48 hours and will be reported as no growth or by number of colony forming unit(CFU)s. The number of CFU of post-intubation swab will be compared with that of pre-intubation swab.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    20 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • anesthesiologists who perform endotracheal intubation and extubation for patients scheduled for endotracheal intubation for elective surgeries
    Exclusion Criteria:
    • none

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Department of Anesthesiology and Pain Medicine Yonsei University College of Medicine Seoul Korea, Republic of

    Sponsors and Collaborators

    • Yonsei University

    Investigators

    • Principal Investigator: Seung Hyun Kim, Severance Hospital

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Yonsei University
    ClinicalTrials.gov Identifier:
    NCT04673006
    Other Study ID Numbers:
    • 4-2020-0529
    First Posted:
    Dec 17, 2020
    Last Update Posted:
    Oct 15, 2021
    Last Verified:
    Oct 1, 2021
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No

    Study Results

    No Results Posted as of Oct 15, 2021